In the evolving landscape of Medicare Advantage, enrollment growth has slowed significantly, with a marked decline in available plans for beneficiaries. As of 2026, the average Medicare beneficiary has access to 32 Medicare Advantage prescription drug (MA-PD) plans, a decrease from 36 in 2024. This trend reflects a broader stagnation in the expansion of extra benefits that had previously been bolstered by federal rebate payments. Concerns have been raised by insurers regarding recent payment adjustments, which they claim have already resulted in reduced benefits and increased costs for enrollees.
Despite these concerns, the Medicare Advantage market shows resilience. Enrollment reached over 35 million in February 2026, with more than half of eligible beneficiaries opting for private plans. While the variety of plan options has decreased in recent years, 2026 still presents more choices than in 2022. An overwhelming majority of beneficiaries have at least one zero-premium plan with prescription drug coverage available to them, alongside other benefits such as vision, dental, and hearing services, which are typically not covered by traditional Medicare.
Still, a significant number of beneficiaries faced abrupt changes in their coverage. Approximately 2.6 million individuals enrolled in MA-PD plans had their coverage terminated at the end of 2025, marking a substantial increase in terminations from the previous year. This affected 13% of all enrollees in individual MA-PDs, a rise from 6% in 2024. The increase in terminations can be attributed to a combination of factors, including a rise in healthcare service utilization and adjustments in federal payments to Medicare Advantage plans.
Availability of Medicare Advantage Plans in 2026
For those impacted by plan terminations, the outlook for 2026 is not as bleak as it may seem. Nearly 99% of Medicare beneficiaries who lost their MA-PD coverage at the end of 2025 will have at least one MA-PD plan option available in the following year. On average, these beneficiaries can choose from 25 different MA-PD plans in their area. Importantly, the majority of those who had previously selected zero-premium MA-PD options still have similar choices in 2026.
More specifically:
- Approximately 68.7% of those affected by terminations will have access to at least one Medicare Advantage plan from the same insurer.
- 29.8% will find options from different insurers, while only 0.4% will have plans exclusively from their previous insurer.
- Just 1.1% of individuals whose plans were terminated will face no MA-PD options in 2026, equating to fewer than 30,000 people nationwide.
Impact on Rural Beneficiaries
Medicare Advantage enrollees in rural areas have been disproportionately affected by these plan terminations. While only 14% of MA-PD enrollees lived in rural counties in 2025, 23% of those whose plans were terminated resided in rural areas. This demographic shift raises concerns about healthcare accessibility for rural populations, especially as terminations in these regions often lead to fewer MA-PD options.
State-by-state analysis reveals a varying impact, with some states experiencing significantly higher termination rates. For instance, in Vermont, over 90% of MA-PD enrollees were in plans that were terminated. In contrast, 12 states saw fewer than 5% of enrollees affected by terminations, showcasing a stark divide in how these changes are experienced across the country.
Market Dynamics and Future Considerations
The Medicare Advantage market is characterized by a concentration of enrollment among a few large insurers. In 2025, UnitedHealth Group and Humana accounted for nearly half of all individual MA-PD enrollments. Interestingly, about 49% of those affected by plan terminations were enrolled in plans offered by smaller insurers, which may pose challenges for competition and market stability.
While concerns about the viability of smaller insurers persist, enrollment data for 2026 indicates that many smaller firms have seen significant growth. For example, Devoted Health, which previously held just 0.8% of enrollment, added over 160,000 enrollees, more than doubling its market share. This suggests that, while some insurers may be consolidating, others are expanding their reach in the Medicare Advantage space.
As beneficiaries begin to navigate their options for 2026, it is crucial to remain informed about the intricacies of Medicare Advantage plans, especially in the wake of terminations. Those affected by coverage changes have the opportunity to explore new plans, potentially leading to different benefits and costs. However, transitioning back to traditional Medicare with a Medigap policy remains a viable option for some.
while the Medicare Advantage landscape is shifting, the availability of options for beneficiaries remains robust, and many individuals will not face significant disruptions in their healthcare coverage. As the enrollment period progresses, beneficiaries are encouraged to review their choices carefully to ensure they select the plan that best meets their needs.
Disclaimer: This article is for informational purposes only and does not constitute professional medical or financial advice.
